NPIL has launched RESPeRATE, a portable electronic device that helps lower blood pressure naturally by enabling the patient to quickly harness the power of paced breathing. RESPeRATE is a patented product developed on the yogic principles of ‘Pranayama’.

Nicholas Piramal India Limited (NPIL) has launched a revolutionary product, RESPeRATE, aimed at the management of hypertension. RESPeRATE is a patented product, developed on the yogic principles of Pranayama. It is the first and only medical device cleared by the USFDA for adjunctive treatment of hypertension.

RESPeRATE is a portable electronic device that helps lower blood pressure naturally by enabling the patient to quickly harness the power of paced breathing. Scientific evidence has shown that paced breathing, if done effortlessly, can lower blood pressure significantly by relaxing the muscles surrounding constricted blood vessels. It is the only medical device for high blood pressure treatment using patented Interactive Respiratory Pacing technology. The device uses the body’s natural tendency to follow external rhythms, interactively guiding the user to effortlessly reduce their breathing rate to a therapeutic zone of less than 10 breaths per minute. The breathing exercises with RESPeRATE relax the constricted muscles surrounding the small blood vessels, allowing the blood to flow more freely and yielding a significant and lasting reduction of blood pressure within weeks. Benefits offered by RESPeRATE include:

• A proven, effective, non-drug approach to lowering high blood pressure
• 14/8 mm Hg average BP reduction within 8 weeks
• No side effects, no drug interactions, pleasant to use
• Well supported with clinical trials

RESPeRATE is manufactured by Intercure Ltd. – an Israeli company founded in 1997 that is headquartered in Fort Lee, New Jersey.